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In the present paper the therapeutic effect of AX/09 preparation containing a mixture of terpene natural oils and AVILIN, a 
thick viscous liquid with anti-infl ammatory, antibacterial and tissue-regenerating properties is studied. The antinociceptive 
and antiedematous activities of AX/09 were investigated in the Randall-Selitto test and carrageenan-induced hind paw edema 
model in rats. The burn wound-healing properties of AX/09 in chemical and thermal burn models were studied in mice and 
rats, respectively. To determine the stage of the wound repair process a few methods were used. The wound surface area was 
measured planimetrically. The development of the granulation tissue and its transformation into young skin, the presence of 
infi ltrates and exudates within the damaged skin were measured micrometrically by skinfold thickness. 
Planimetric observations of the wound surface area and micrometric measurements of effusions and infi ltrates showed that 
the healing process of the chemically-induced burn wound was more balanced and much faster after treatment with AX/
09. In this model, in animals treated with AX/09 the whole granulation tissue was transformed into young epidermis after 
17 days, while in the group treated with AVILIN and in the control group a similar effect was observed after 20 and 23 days, 
respectively. Much less convincing results were observed in animals treated with AX/09 in thermally-induced burn models. 
In animals treated with AX/09 complete wound closure by the newly formed epidermis was observed after 21 days. In the 
group treated with vehiculum a similar effect was observed after 22 days and in the control group after 24 days. There were 
no toxic skin reactions after the fi rst contact with the skin, as well as after multiple applications of AX/09. AX/09 did not 
cause a delayed-type allergic reaction. The effi cacy of AX/09 and its infl uence on the burn wound healing process, especially 
in chemical models, seems to be of special value for the clinical, especially dermatological, practice. 
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INTRODUCTION
The most relevant role of the skin is the protec-
tion of inner parts of the body from pathogens and 
damage coming from the external environment. 
Apart from this protective role against mechani-
cal, physical and chemical factors it also regulates 
the heat, secretory and resorbing activities and 
immune processes (ADAM et al., 1968).
The skin aging process inhibits the synthesis 
of collagen and proteoglycans and leads to the im-
pairment of angiogenesis (ADAM et al., 1968) which 
plays an important role in embryogenesis and is 
essential for such processes as the hair cycle and 
wound healing (ADAM et al., 1968). The mechani-
sm of skin cell damage is diffi cult to determine 
but it is usually connected with the damage to one 
of four intracellular systems: aerobic respiration, 
cell membrane, synthesis of enzymes and struc-
tural proteins, and the genetic apparatus repair 
systems. There is evidence that the onset and ac-
celeration of the skin aging process is associated 
with the action of oxygen free radicals produced 
in the skin. Free oxygen radicals can react with 
many components of skin cells causing peroxi-
dation of the genetic material and lipids, which 
results in the damage to the cell membranes, inhi-
bition of prostacyclin synthesis and inactivation of 
enzymes. Under physiological conditions there is 
a large variety of free radical-scavenging mecha-
nisms the human organism is supplied with. One 
of them is the superoxide dismutase which cataly-
zes decomposition of peroxide radicals.  
Burn not only disturbs the function of the skin 
but it also exposes the whole body to many dange-
rous factors from the environment. The extension 
and depth of burn wounds depend on the tem-
perature, duration of heating and cooling of the 
tissue. There are numerous causes of burns and 
therefore they are classifi ed as thermal, chemical, 
electrical and radiant burns (POTOCKI, 1987).  Ther-
mal burns are caused by high temperatures, and 
their severity depends on the temperature and time 
of contact with the skin. Skin damage caused by 
high temperatures is a consequence of coagulation 
necrosis with changes within the capillaries. This 
leads to increased vascular permeability and loss 
of both plasma and electrolytes. Chemical burns 
occur as a result of exposure of the skin or the 
mucous membranes to caustic liquids, such as 
concentrated acids, alkalis or salts of some heavy
metals. This leads to necrosis of the affected sur-
face. The depth of chemical burns depends on the 
concentration of acids or alkali and the time of 
their action (MOUNTAINEER, 1992). Burn leads to 
coagulative necrosis which does not undergo tis-
sue autolysis but is rejected by demarcation. Insu-
sceptibility of necrotic collagen to skin collagena-
se causes delayed regeneration, characteristic of 
burn wounds in comparison with incised wounds,
(KOPEC-SZLĘZAK, 1985). Additionally, changes in 
electrolyte levels at the site of the burn wound and 
even in the blood serum are also important. The 
most prominent one is the escape of potassium 
ions; they become replaced by sodium ions, which 
results in excessive swelling, enhances infl amma-
tory processes and delays the regeneration. It is 
a very well-known fact that severe, extensive and 
deep burns may be the cause of death. Therefore, 
the consequences of burns causing clinical and 
metabolic disorders are called “burn disease” (PO-
TOCKI, 1987). 
Proper skin tissue regeneration comprises va-
scular regeneration, connective regeneration and 
epithelial regeneration. Regeneration of epidermis 
after deep burns depends not only on the degree 
and extent of its destruction but also on the de-
gree of skin damage (POTOCKI, 1987). Conditions in 
which vascular regeneration takes place are not 
fully understood yet. However, the mechanisms of 
connective and epithelial regeneration are relati-
vely well-known. Two antagonistic hormonal sy-
stems: somatropin (STH) with androgen and deo-
xycorticosterone and corticotropin (ACTH) with 
glucocorticoids and foliculin play a signifi cant role 
in it.  In addition to the endocrine system, some 
vitamins are involved in the regeneration process: 
vitamin B12 which supports the action of STH and 
mineralocorticoids, vitamins A, C, PP, B2 which fa-
cilitate the tissue regeneration processes through 
their direct effect on collagen, and vitamin E whi-
ch supports directly the effect of ACTH and gluco-
corticoids (DIOUFA et al., 2010). 
AVILIN (Vinylinum, polyvinylbutylic ether) is 
a light yellow, thick viscous liquid, characteri-
zed by specifi c odour and minimally soluble in 
water. It has been shown to have anti-infl am-
matory, antibacterial and tissue-regenerating 
properties. AVILIN is used in the treatment of 
wounds and ulcers. It affects epithelization and 
tissue regeneration. Vinylinum is also used in ab-
scesses, boils, ulcers of digestive tract, abcessed 
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wounds, infl ammatory states of the mammary 
gland, frostbites and infl ammatory diseases, to 
treat injuries, wounds and burns of various de-
gree (ADAM et al., 1968; BAZHENOV, 1950; TIKHONO-
VA et al., 1970). Internally AVILIN can be used in 
the treatment of peptic ulcers in the stomach and 
duodenum, catarrh and colic (BENES, 1960; KOLE-
SOV, 1966; POTOCKI, 1987). The lotion acts protec-
tively on erosions, accelerates regeneration of the 
mucosa and has some anesthetic and anti-infl am-
matory properties. It is completely safe after oral 
administration as its particles are not absorbed 
from the gastrointestinal tract (BALON, 1977; VI-
TALYEVA et al., 1967). 
Essential oils have been widely used in medi-
cine and in production of perfumes and cosme-
tics for centuries. They are important both in the 
treatment of different types of wounds and in re-
vitalizing the skin (LANS, 2007; SHETTY et al., 2006; 
SHIM et al., 2007; SHUKLA et al., 1999; STEVENSON et 
al., 2002; UPADHYAY et al., 2009a; UPADHYAY et al., 
2009b; ZHUANG et al., 2009). They have the abili-
ty to stimulate cellular metabolism and improve 
the skin structure as they accelerate regenerative 
processes of the cells (KAMATH et al., 2003; KOLE-
SOV, 1966).  Essential oils improve blood supply to 
the skin, which makes the skin more fl exible. By 
regulating the secretion of fatty substances they 
restore skin equilibrium. It has also been demon-
strated that essential oils have local anaesthetic 
and anti-infl ammatory properties, which may be 
very valuable in medicinal practice (HARISH et al., 
2008; LANS, 2007; LIU et al., 2008). 
In the present paper the therapeutic effect of 
AX/09 containing a mixture of terpene natural oils 
and AVILIN as vehiculum is studied. The antinoci-
ceptive, antiedematous and burn wound-healing 
properties of AX/09 in chemically- or thermally-
induced burn models are investigated.
MATERIALS AND METHODS
Chemicals
The reference drugs used – indomethacin and ibu-
profen – were provided by Sigma Aldrich (Germa-
ny). Polyvinylbutylic ether (AVILIN) was supplied 
by NES Pharma (Poland); thiopentone sodium was 
purchased from Werner W. (Germany); 40% hy-
drobromic acid solution (Hydrobromic acid 40% 
pure) and 0.9% NaCl solution were provided by 
Polskie Odczynniki Chemiczne (Polish Chemical 
Reagents, Poland).
Test equipment
The development of carrageenan-induced paw 
edema was measured with the use of plethysmo-
meter (Ugo Basile Plethysmometer, Type 7140). 
In the Randall-Selitto test the pain threshold was 
measured by means of analgesiameter (Ugo Basile 
Analgesy Meter, Type 37215).
Animals
The experiments were carried out at the Depart-
ment of Pharmacodynamics, Jagiellonian Uni-
versity, Medical College in Cracow and at the 
Department of Pharmaceutical Technology and 
Biotechnology, Saratov State Medical University, 
Russia. Adult male Albino Swiss mice weighing 
18-30 g, male Albino Wistar rats (180-250 g) and 
guinea pigs (250-300 g) were used in the expe-
riments. The animals were kept in groups of 15 
mice or 3 rats in cages at a room temperature of 
22±2o C, under light/dark (12:12) cycle and had 
free access to food and water before the experi-
ments. Each experimental group consisted of 6-
12 animals/dose and each animal was used only 
once. Before the experimentation the animals 
were habituated to the vivarium for a minimum of 
72 h. The experiments were performed between 8 
a.m. and 3 p.m. The procedures were approved by 
the Local Ethics Committees of the Jagiellonian 
University in Cracow and Saratov State Medical 
University, Russia.
Experiments
Anti-infl ammatory activity of AX/09 in the 
carrageenan-induced hind paw edema model
Male albino Wistar rats used in the hind paw 
edema test were divided into four groups, one of 
which was the control. To induce infl ammation, 
0.1 ml of 1% carrageenan solution in water was 
injected into the subplantar tissue of the hind 
paw. Prior to this, paw diameters were measu-
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red. The development of paw edema was mea-
sured plethysmographically. After carrageenan 
injections, the investigated AX/09 ointment was 
applied at a constant volume of 0.2 ml by smea-
ring the exact volume of the formulation over the 
entire surface of the swollen feet, 1, 2, 3 and 23 
h after the carrageenan injection. Indomethacin 
(gel and ointment -Metindol)) and ibuprofen (gel) 
were used as the reference drugs and they were 
applied to the swollen rat paw in a way similar to 
that used for AX/09. Measurements were made 
six times: for the fi rst time before the injection of 
carrageenan, at the peak point of swelling, after 
the third postinjection hour, three times at one-
hour intervals from the peak infl ammation point, 
and after 24 h.  The degree of inhibition of rat paw 
edema accumulation, expressed as %, was calcu-
lated by the formula:
K = average increase in the volume of the rat 
paw in the control group at the appointed hour, 
d = average increase in the volume of the rat paw 
after the administration of the investigated com-
pound at the appointed hour (WINTER et al., 1962).
Analgesic activity in the Randall-Sellito test
To induce infl ammation 0.1 ml of a carrageenan 
solution in saline was injected subcutaneously 
into the plantar surface of the left hind paw of 
the rat. After carrageenan injection, the investiga-
ted AX/09 ointment preparation was applied at a 
constant volume of 0.2 ml by smearing the exact 
volume of the formulation over the entire surface 
of the swollen feet, 1, 2, 3 and 23 h after injec-
tion of carrageenan. Indomethacin (gel and oint-
ment – Metindol)) and ibuprofen (gel) were used as 
the reference drugs and they were applied to the 
swollen rat paw in a way similar to that used for 
AX/09. After the third hour (i.e. at the top point 
of swelling), using an analgesia meter, pressure 
was applied through the tip to the plantar surfa-
ce of the rat’s foot, at a constant rate (expressed 
in g), to the point at which the animal struggled, 
squealed or attempted to bite. The increase in the 
pain threshold (in %) was calculated by subtrac-
ting the force applied to the control group from 
the force applied to the drug group, and dividing 
the difference by the force applied to the control 
group. The percentage of analgesia was calculated 
according to the following formula: 
% analgesia = ( 100 x B )/A – 100
Where: A = mean pressure (in g) for the control 
group; B = mean pressure (in g) for the test group 
(RANDALL and SELITTO, 1957).
Determination of irritant action of AX/09
Studies were carried on white male guinea pigs. 
The animals received a standard diet and drinking 
water ad libitum. Experiments were carried out in 
two groups of animals: the test group (15 AX/09-
treated animals) and the control group (10 animals 
treated with vehiculum). Every day for 10 days 0.5 
g of AX/09 or vehiculum was applied by smearing 
(not rubbing) it on guinea pig’s right side of the 
body. The reaction was induced on the surface 
area of 5 x 5 cm under a loose bandage with ste-
rile gauze and cellophane. Skinfold thickness was 
measured with a caliper (accuracy of 0.05 mm) 
before and on the last day of the experiment.  The 
results were checked daily for 10 days. The deve-
lopment of erythema and an increase in skinfold 
thickness in 50% of the tested animals was regar-
ded as a positive result. 
Evaluation of allergenic properties 
of AX/09 – ability to cause delayed 
contact allergy
The aim of the test was to determine whether the 
tested preparation can be an antigen that causes a 
delayed hypersensitivity reaction in normal guinea 
pigs and to assess whether the substrate prepa-
ration causes delayed skin allergy. The study was 
carried out on white male guinea pigs. The animals 
were divided into two groups: the control group (10 
animals treated with vehiculum) and the test group 
(15 animals treated with AX/09). Every day for 8 
days approximately 0.1 g of the investigated AX/09 
or vehiculum was applied by smearing it on the 
shaved and degreased with alcohol and ether  right 
side of the guinea pig’s skin (surface area 5 x 5 cm) 
(the induction phase). If there was no response, 
51Wound Healing Properties of AX/09
then on the 15th day of the experiment, on the left 
side of the guinea pig’s skin, 0.01 g of the evoking 
dose of the investigated AX/09 or vehiculum diluted 
10 times was applied (the expression phase). The 
results which caused a rash, skin changes and an 
increase in skinfold thickness measured with a ca-
liper 24, 48 and 72 h after applying the evoking 
dose, were considered as positive. 
Chemical burn induced 
by 40% hydrobromic acid
Contact burns were induced by the use of a stamp 
pad moistened with 40% hydrobromic acid solu-
tion and placed for 2 min on the mouse body being 
under general anesthesia (thiopentone sodium – 
75 mg/kg; intraperitoneal administration). Then, 
the burnt surface was washed with plenty of 0.9% 
NaCl and dried with sterile gauze. After the burn 
had been induced, the animals were divided into 
three groups:
Group I – animals without any treatment
Group II – animals treated with vehiculum (AVI-
LIN)
Group III – animals treated with AX/09
The investigated preparation (AX/09) or vehi-
culum (0.1 g) was applied to the wound once a day 
until the complete healing was achieved. AX/09 
and vehiculum were used for the fi rst time 24 h 
after the burn and then every 24 h for 20 days 
after washing the wounds with 0.9% NaCl and 
drying with sterile gauze. The surface area of the 
burn wound was thoroughly evaluated every 24 
h. Furthermore, the burn wound surface area was 
measured planimetrically on the 4th, 7th, 9th, 12th, 
16th, 19th and 22nd day after the burn. Skinfold thi-
ckness was measured before the burn and 4, 7, 
9, 12, 16, 19 and 22 days after the burn. At the 
same time the appearance of the burn wound, i.e. 
the size and appearance of the scab, infi ltration, 
swelling or redness were observed. The wound was 
considered healed when the defect was completely 
covered by the newly formed epidermis. 
Thermal burns
Contact burns of 2 cm2 were made in rats under 
general anaesthesia (thiopentone sodium; 75 mg/
kg, intraperitoneal administration) using a heated 
to 100oC copper tip for 12 s. The animals were di-
vided into 3 groups:
Group I – animals without any treatment (con-
trol group)
Group II – animals treated with vehiculum
Group III – animals treated with AX/09
0.2 g of AX/09 or vehiculum was applied to the 
wound once a day until the complete healing of the 
wound was achieved. The surface area of the burn 
wound was measured planimetrically 5, 7, 9, 13, 
15, 19, 21 and 24 days after the burn. Skinfold 
thickness was measured before and after the burn 
(i.e. after 5, 7, 9, 13, 15, 19, 21 and 24 days). At 
the same time the appearance of the burn wound 
(i.e. the size and appearance of the scab, infi l-
tration, swelling and redness) was observed. The 
wound was considered healed when the defect 
was completely covered by the epidermis.
Statistical analysis
Student’s t-test was used to determine the si-
gnifi cance of differences between the mean values 
obtained for the control and treatment groups, to 
evaluate statistically the results concerning the 
burn wound and skinfold thickness. Differences 
were considered signifi cant when p<0.05.
 
RESULTS
Analgesic and antiedematous effects 
in the carrageenan-induced hind paw edema
Polyvinylbutylic ether, AX/09 as well as the refe-
rence drugs did not show the antinociceptive effect 
in the Randall-Selitto test. However, in the carra-
geenan-induced paw edema test, in the second and 
third hour of observation, both polyvinylbutylic 
ether (AVILIN) and AX/09 showed a greater antie-
dematous effect than indomethacin or ibuprofen. 
AVILIN showed the strongest antiedematous effect 
as compared with the reference compounds (Fig. 1). 
Evaluation of the irritant effect
The investigated preparation applied topically eve-
ry 24 h for 10 days did not lead to infl ammatory 
changes in experimental animals. Toxicodermal 
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reactions (erythema, increase in skinfold thickness) 
after treatment with AX/09 also did not occur after 
the fi rst application to the skin or after 10 days. The 
vehiculum did not show an irritating effect either.
Evaluation of allergenic properties of 
AX/09 (ability to cause delayed 
contact allergy)
In order to determine the ability of AX/09 to indu-
ce symptoms of the late-type immune response, 
the infl uence on the formation and spreading of 
erythema and the formation of exudate and swel-
ling of the skin was evaluated. Neither AX/09 
nor vehiculum demonstrated positive reactions 
(erythema or swelling) in the animals tested.  The 
control animals also did not react positively. 
Chemical burn in mice
In this study the surface area of the burn wound 
was evaluated and the skinfold thickness was 
measured planimetrically before and after the 
burn. Four days after the burn had been indu-
ced, the surface area of the wound was: 136.62 
mm2 (control mice), 103.20 mm2 (vehiculum-trea-
ted animals), and 80.50 mm2 (AX/09-treated 
animals). The results were statistically signifi cant 
(for AX/09 at p <0.01). After 9 days the wound 
size in the control group was 86.62 mm2, in the 
vehiculum-treated group – 46.20 mm2 and in the 
mice treated with AX/09 – 32.70 mm2. After 16 
days the wound surface area was: 15.87 mm2, 
5.80 mm2 and 2.5 mm2, respectively (Table 1). 
Comparing the surface area of the wound after 16 
days with that after 12 days, the wound size was 
4 times smaller in the group treated with AX/09 
and approximately 3 times smaller in the vehi-
culum- and control- treated mice (Table 1). Com-
paring in turn the surface area of the wound after 
16 days with that after 4 days, the wound size 
was 30 times smaller in the mice treated with 
AX/09, nearly 18 times smaller in the animals 
treated with vehiculum and nearly 9 times smaller 
in the control group. The increase in skinfold thi-
ckness measured 4 days after the burn was 1.98 
Fig. 1. Antiedematous effects of AX09, AVILIN and the reference drugs on carrageenan-induced paw edema
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TABLE 1. The infl uence of AX/09 and vehiculum (AVILIN) on the average surface area (in mm2) of chemically-induced burn 
wounds in mice 
Day of measurement CONTROL average AVILIN average AX/09 average
4
179
133
135
160
126
152
102
106
136.625
145
75
105
79
50
140
110
83
155
90
103.2a
80
75
73
67
110
81
72
66
75
106
80.5c
7
153
110
125
150
113
104
82
85
115.25
105
50
55
55
50
140
80
65
92
50
74.2 b
30
55
50
25
75
40
42
30
60
100
50.7 c
9
143
76
107
97
90
81
58
41
86.625
67
25
25
44
40
90
45
50
45
31
46.2 c
15
25
25
12
50
25
35
25
40
75
32.7 c
12
88
50
59
42
50
29
25
17
45.0
20
15
0
20
20
40
7
15
18
10
16.5 c
0
15
7
0
15
10
0
0
10
41
9.8 c
16
65
25
13
0
15
0
0
9
15.875
0
0
0
0
23
35
0
0
0
5.8 c
0
0
0
0
0
0
0
0
25
2.5 c
19
35
13
0
0
10
0
0
7.25
0
0
0
0
0
20
0
2.0 c
0
0
0
0
0
0
0
0 c
22
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
The burn wound induced by the use of 40% hydrobromic acid solution
Signifi cant difference (Student’s t-test) compared with the vehicle-treated group: ap< 0.05;
bp< 0.01; cp< 0.001
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mm in the control group, 1.5 mm in the vehicle-
treated group, and 1.33 mm in the group treated 
with AX/09. The results were statistically signifi -
cant (p <0.01). After 9 days, in the case of mice, 
the increase in skinfold thickness was: in the 
control animals – 1.75 mm; in the vehicle-treated 
ones – 1.06 mm, and the in AX/09-treated mice 
– 0.86 mm. These results were not statistically 
signifi cant. After 16 days the increase in skin-
fold thickness was: in the control group – 0.962 
mm, in the vehicle-treated group – 0.67 mm, and 
in the group treated with AX/09 – 0.32 mm (Ta-
bles 2, 2A, 2B). 
After 4 days in most control animals the woun-
ds were open, oozing, only in a few cases covered 
with a dry scab. The same effect was observed 
in the vehicle-treated group. In contrast, in ani-
mals treated with AX/09, wounds were mostly 
dry and covered with thin scabs over the entire 
surface. In this group an early stage of the gra-
nulation process could be observed and it was 
demonstrated by the presence of the “epidermal 
seam” (i.e. a red stripe at the border of the skin 
and the granulation tissue). On the 10th day in 
the control group the wounds were mostly co-
vered with dark, semi-protruding scabs. In the 
group treated with the vehicle, in half of the ani-
mals the scabs fell off. In the vast majority of ani-
mals treated with AX/09 no scabs were observed, 
moreover, the early skin formation process had 
begun. On the 17th day the wounds were com-
pletely healed and covered by the newly formed 
epidermis in all the mice treated with AX/09, in 
80% of the animals in the vehicle- treated group 
and in 50% of the animals in the control group 
(Table 3). The complete healing of the wound in 
100% of the control animals was found on the 
23rd day of observation. 
Thermal burn in rats
After 5 days the burn wound surface area in con-
trol rats was 153.4 mm2, in the vehicle-treated 
group – 155.4 mm2, and in the rats treated with 
AX/09 – 154.8 mm2 (Table 4). After 13 days the 
burn wound surface area in the control group was 
58.8 mm2, and in the vehicle-treated group – 52.4 
mm2. In the group treated with AX/09 the burn 
wound size was the same as that in the vehicle-
treated group (Table 4). Nineteen days after the 
burn the wound surface area in the control, vehi-
cle-treated and AX/09-treated groups was 9.2 
mm2, 3.4 mm2 and 2.0 mm2, respectively (Table 4). 
Comparing the surface area of the wound 19 days 
after the burn with that after 5 days, it was ap-
proximately 16 times smaller in the control group, 
approximately 45 times smaller in the vehiculum-
treated group and almost 80 times smaller in the 
group treated with AX/09 (Table 4). Skinfold thi-
ckness measured 5 days after the burn was 5.26 
mm in the control group, 5.88 mm in the vehicle-
treated group, and 5.06 mm in the group treated 
with AX/09 (Table 5, 5A, 5B). After 13 days the 
skinfold thickness in the control-, vehicle- and 
AX/09- treated groups was 4.06 mm, 3.04 mm 
and 2.74 mm, respectively. After 19 days, the 
skinfold thickness was 2.2 mm in the control 
group, 1.36 mm in the vehicle-treated group and 
1.26 mm in the AX/09–treated group (Table 5, 
5A, 5B). Five days after the burn the wounds in 
the majority of animals in all the groups were dry, 
but in some cases they were open and oozing. On 
the 9th day of observation the wounds in the con-
trol group were dry and sealed, covered with dark 
scabs. In the animals treated with the vehiculum 
and AX/09 the wounds were dry and the scabs 
partly fell off. Moreover, there was clearly visible 
red granulation tissue. After 15 days the woun-
ds in the control group were covered with thin 
scabs. The same effect was observed in the vehi-
culum-treated group. In this group the newly for-
med epidermis was noticeable. In animals treated 
with AX/09 an advanced stage or even the com-
pletion of the granulation process was observed. 
On the 17th day after the burn the wounds in the 
control group and in the vehiculum-treated group 
were still covered with small scabs. In some ani-
mals there was epidermis, which was demonstra-
ted by the presence of the “epidermal seam”. In 
animals treated with AX/09 the wounds were 
without scabs. The process of wound healing had 
begun. After 21 days the wounds in the control 
group and the vehiculum-treated group were co-
vered by epidermis and in 50% of the animals the 
healing process could be observed. In animals 
treated with AX/09 the wounds were completely 
covered by epidermis and the process of repara-
tion was already fi nished. In the vehiculum-trea-
ted group and the control group the reparation 
process was completed after 22 and after 24 days, 
respectively (Table 6). 
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TABLE 2. The increase in skinfold thickness (Δl) in control mice (Chemical burn - HBr) 
lo l1 Δl1 l4 Δl4 l7 Δl7 l9 Δl9 l12 Δl12 l16 Δl16 l19 Δl19 l22 Δl22
1. 5 12 7 25 20 23 18 23 18 21 16 19 14 13 8 8 3
2. 4 12 8 35 31 28 24 28 24 20 16 17 13 12 8 6 2
3. 4 12 8 23 19 23 19 23 19 21 17 19 15 10 6 6 2
4. 6 13 7 23 17 24 18 22 16 20 14 15 11 10 4 7 1
5. 4 10 6 25 21 24 20 23 19 20 16 14 10 10 6 6 2
6. 7 13 6 25 18 25 18 22 15 17 10 10 3 10 3 9 2
7. 6 13 7 21 15 20 14 20 14 15 9 10 4 8 2 7 1
8. 5 11 6 22 17 22 17 20 15 17 12 12 7 8 3 5 0
Ave-
rage 6.875 19.75 18.5 17.5 13.75 9.62 5.0 1.625
Ave-
rage
in 
mm
0.6875 1.975 1.85 1.75 1.375 0.962 0.5 0.162
TABLE 2A. The increase in skinfold thickness (Δl) in the vehiculum-treated mice (Chemical burn – HBr)
lo l1 Δl1 l4 Δl4 l7 Δl7 l9 Δl9 l12 Δl12 l16 Δl16 l19 Δl19 l22 Δl22
1. 5 12 7 20 15 18 13 18 13 15 10 13 8 9 4 7 2
2. 4 10 6 23 19 21 17 20 16 13 9 10 6 8 4 6 2
3. 3 12 9 14 11 14 11 12 9 11 8 9 6 6 3 4 1
4. 4 11 7 18 14 20 16 18 14 16 12 10 6 6 2 4 0
5. 5 12 7 21 16 19 14 17 12 16 11 13 8 7 2 6 1
6. 4 8 4 22 18 22 18 22 18 19 15 15 11 12 8 6 2
7. 4 12 8 17 13 16 12 16 12 14 10 10 6 7 3 4 0
8. 4 11 7 19 15 17 13 11 7 10 6 8 4 6 2 4 0
9. 5 14 9 17 12 18 13 17 12 15 10 10 5 7 2 6 1
10. 3 9 6 20 17 19 16 19 16 15 12 10 7 5 2 5 2
Ave-
rage 7.0 15 14.3 10.6 10.3 6.7 3.2 1.1
Ave-
rage
in 
mm
0.7 1.5a 1.4 a 1.1 a 1.0 0.7 0.3 a 0.11
Signifi cant difference (Student’s t-test) compared with the vehicle-treated group: ap< 0.05
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TABLE 2B. The increase in skinfold thickness (Δl)  in mice treated with AX/09 (Chemical burn – HBr)
lo l1 Δl1 l4 Δl4 l7 Δl7 l9 Δl9 l12 Δl12 l16 Δl16 l19 Δl19 l22 Δl22
1. 5 10 5 15 10 11 6 8 3 7 2 7 2 6 1 5 0
2. 3 10 7 18 15 16 13 14 11 11 8 5 2 6 3 4 1
3. 6 12 6 16 10 14 12 11 5 8 2 7 1 8 2 8 2
4. 4 10 6 18 14 15 11 12 8 8 4 6 2 6 2 5 1
5. 3 13 10 29 26 25 22 20 17 16 13 10 7 6 3 4 1
6. 3 9 6 14 11 14 11 11 8 10 7 7 4 4 1 3 0
7. 4 10 6 13 9 13 9 13 9 8 4 7 3 6 2 5 1
8. 6 12 6 20 14 18 12 10 4 9 3 8 2 7 1 6 0
9. 5 13 8 16 11 14 11 13 8 11 6 7 2 7 2 6 1
10. 4 12 8 17 13 16 12 17 13 16 12 11 7 6 2 4 0
Ave-
rage 6.8 13.3 11.9 8.6 6.1 3.2 1.9 0.7
Ave-
rage
in 
mm
0.68 1.33a 1.19b 0.86a 0.61c 0.32c 0.19c 0.07c
Signifi cant difference (Student’s t-test) compared with the vehicle-treated group: ap< 0.05; bp< 0.01; cp< 0.001
TABLE 3. The infl uence of AX/09 and AVILIN on the time needed for burn wounds to heal completely as compared with the 
control group (Chemical burn – HBr)
10 
days
11 
days
12 
days
13 
days
14 
days
15 
days
16 
days
17 
days
18 
days
19 
days
20 
days
21 
days
22 
days
23 
days
CONT-
ROL 0/8 0/8 0/8 0/8 1/8 1/8 3/8 4/8 4/8 5/8 6/8 6/8 7/8 8/8
AVILIN 0/10 0/10 1/10 4/10 6/10 6/10 8/10 8/10 8/10 9/10 10/10
AX/09 1/10 2/10 4/10 5/10 8/10 8/10 9/10 10/10
x/y – the number of animals with the completed healing process per number of all animals in the group 
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TABLE 4. The infl uence of AX/09 and vehiculum (AVILIN) on the average surface area (in mm2) of temperature-induced  burn 
wounds in rats as compared with the control group 
Day of 
measurement Control average AVILIN average AX/09 average
5
180
187
137
146
117
153.4
137
167
159
156
158
155.4
157
167
134
159
157
154.8
7
132
125
117
132
94
120.0
137
127
113
121
123
124.2
125
105
128
110
121
117.8
9
100
105
98
125
88
103.2
118
108
98
102
108
106.8
98
95
118
93
115
103.8
13
50
51
52
97
44
58.8
51
58
54
48
51
52.4
45
61
55
40
61
52.4
15
30
41
51
57
19
39.6
21
18
34
13
19
21.0a
10
6
13
8
20
    11.4c
19
11
7
11
11
6
9.2
5
0
0
7
5
3.4c
0
0
0
10
0
2.0c
21
6
0
0
8 2.8
3
0
0
5 1.6
a
0
0
0
0 0
c
24
0
0
0
0 0
0
0
0
0 0
0
0
0
0 0
Signifi cant difference (Student’s t-test) compared with the vehicle-treated group:
ap< 0.05; cp< 0.001
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TABLE 5.  The increase in skinfold thickness (Δl)  in the control rats (Thermal burn)
l0
Day 
5
Δl5
Day 
7 
Δl7
Day 
9 
Δl9
Day 
13 
Δl13
Day 
15 
Δl15
Day 
19 
Δl19
Day 
21  
Δl21
Day 
24 
Δl24
1. 11 65 54 82 71 74 63 40 29 34 23 29 18 20 9 16 5
2. 11 62 51 90 79 69 58 50 39 47 36 30 19 23 12 14 3
3. 13 68 55 72 57 80 67 64 51 61 48 40 27 25 12 20 7
4. 12 67 55 67 55 72 60 68 56 57 45 40 28 30 18 18 6
5. 12 60 48 68 56 74 62 40 28 35 23 30 18 22 10 17 5
Ave-
rage
52.6 63.6 62.0 40.6 35.0 22.0 12.2 5.2
Ave-
rage 
in 
mm
5.26 6.36 6.2 4.06 3.5 2.2 1.22 0.52
TABLE 5A. The increase in skinfold thickness (Δl) in rats treated with vehiculum (Thermal burn)
l0
Day 
5 
Δl5
Day 
7 
Δl7
Day 
9 
Δl9
Day 
13 
Δl13
Day 
15 
Δl15
Day 
19 
Δl19
Day 
21  
Δl21
Day 
24 
Δl24
1. 9 67 58 80 71 67 58 45 36 34 25 30 21 28 19 15 6
2. 10 75 65 68 59 52 42 36 26 28 18 24 14 20 10 14 4
3. 11 69 58 74 63 64 53 40 29 34 23 20 9 17 6 14 3
4. 10 66 56 50 40 57 47 40 30 27 17 24 14 20 10 15 5
5. 10 67 27 59 49 58 48 41 31 31 21 20 10 18 8 13 3
Ave-
rage
58.8 56.4 49.6 30.4
20.8
13.6 10.6 4.2
Ave-
rage 
in 
mm
5.88 5.64 4.96a 3.04 2.08a 1.36 1.06 0.42
Signifi cant difference (Student’s t-test) compared with the vehicle-treated group: ap< 0.05
TABLE 5B. The increase in skinfold thickness (Δl) in rats treated with AX/09  (Thermal burn)
l0
Day 
5 
Δl5
Day 
7 
Δl7
Day 
9 
Δl9
Day 
13 
Δl13
Day 
15 
Δl15
Day 
19 
Δl19
Day 
21 
Δl21
Day 
24 
Δl24
1. 9 46 37 54 45 52 43 35 26 27 18 22 13 17 8 12 3
2. 12 66 54 52 40 50 38 41 29 34 22 23 11 21 9 16 4
3. 12 59 47 62 50 60 48 38 26 25 13 20 8 19 7 17 5
4. 10 66 56 59 49 52 42 41 31 32 22 27 17 20 10 16 6
5. 10 69 59 64 54 38 28 35 25 27 17 24 14 19 9 13 3
Ave-
rage
50.6 47.6 39.8 27.4 18.4 12.6 8.6 4.2
Ave-
rage
in 
mm
5.06 4.76a 3.98a 2.74c 1.84c 1.26c 0.86c 0.42
Signifi cant difference (Student’s t-test) compared with the vehicle-treated group: ap< 0.05; cp< 0.001
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TABLE 6. The infl uence of AX/09 and vehiculum (AVILIN) on the time needed for burn wounds to heal completely as compa-
red with the control rats (Thermal burn) 
x/y – the number of animals with the completed healing process per number of all animals in the group
Day 17 Day 18 Day 19 Day 20 Day 21 Day 22 Day 23 Day 24 
CONTROL 0/5 0/5 0/5 1/5 3/5 3/5 4/5 5/5
AVILIN 0/5 1/5 2/5 3/5 3/5 5/5
AX/09 1/5 3/5 4/5 4/5 5/5
DISCUSSION
The aim of this study was to analyze the burn 
wound healing process and the infl uence of AX/09 
preparation on it. The comparison of pharmaco-
logical properties of AX/09 and vehiculum (AVI-
LIN) would provide data to clarify the therapeutic 
value of AX/09. The present study demonstrated 
that the investigated AX/09 administered locally 
showed high antiedematous activity in the car-
rageenan test (Table 1). Anti-infl ammatory and 
analgesic activities of the investigated AVILIN and 
AX/09 were more satisfactory than those of the re-
ference compounds. To determine the stage of the 
wound repair process a few methods were used. 
The wound surface was measured planimetrical-
ly. The development of the granulation tissue and 
its transformation into young skin, the presence 
of infi ltrates and exudates within the damaged 
skin were measured micrometrically by skinfold 
thickness. Planimetric observations of the surface 
area of experimental animal wounds and micro-
metric measurements of effusions and infi ltrates 
showed that the healing process of the chemical-
ly-induced burn wound was more balanced and 
much faster after treatment with AX/09. The hea-
ling process in the control- and vehiculum-treated 
groups was much slower as compared with the 
AX/09-treated group, with a clear delay in the de-
velopment of the granulation tissue and formation 
of young epidermis. The process of granulation 
and epithelialization progressing from the edges 
of the wound was more advanced in the skin of 
animals treated with AX/09, with highly signifi -
cant regression of wound infl ammation manife-
sted by faint effusion. Elimination of the necrotic 
tissue (scabs), especially in chemical burns, was a 
result of the proliferation of the granulation tissue 
and its transformation into epidermis, and it was 
most intense in animals treated with AX/09. It 
should be emphasized that in chemically-induced 
burn wounds in animals treated with AX/09 the 
whole granulation tissue was transformed into 
young epidermis after 17 days.  In contrast, in 
the control group and in the group treated with 
vehiculum such epithelial cells occurred rarely or 
in small numbers. Presumably, the reasons for 
the above effects are better conditions for wound 
healing caused by interaction of the wound with 
the AX/09 preparation. A similar effect, i.e. fully 
healed chemical wounds, in the control group and 
the group treated with AVILIN was observed after 
23 and 20 days, respectively. 
Much less convincing results were observed in 
the case of animals treated with AX/09 in ther-
mally-induced burn models. It concerns mainly 
the fi rst days after the burn during which AX/09 
did not show any therapeutic effect. Therapeutic 
effects – rapidly progressing granulation and epi-
thelialization with disappearing effusion could be 
observed after 17 days of treatment.  However, after 
21 days in animals treated with AX/09 complete 
wound closure by the newly formed epidermis was 
observed; simultaneously, dermis reconstruction 
in the burn area took place. In the group treated 
with vehiculum a similar effect was observed after 
22 days, and in the control group after 24 days. 
In clinical practice, for drugs used topically it 
is important that they have no toxicodermal or al-
lergenic effects, especially anaphylactic or contact 
type effects. Experiments conducted on guinea 
pigs showed that AX/09, as well as the vehiculum, 
did not cause irritation or infl ammation of the 
skin. There were no toxic skin reactions after the 
fi rst contact with the skin, as well as after multiple 
applications of AX/09. Taking into consideration 
the fact that the guinea pig skin is commonly used 
for the determination of toxic or allergenic proper-
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ties, the investigated AX/09 can be regarded as 
safe for the skin. As the reactivity of human skin 
is similar to the reactivity of guinea pig skin, it can 
be assumed that the investigated preparation will 
not cause toxic, irritant or allergenic reactions in 
humans. AX/09 did not cause a delayed-type al-
lergic reaction which, contrary to the toxic effects, 
can occur after some time and at a distant site, 
even far from the site of antigen application. 2,4-
dinitrochlorobenzen (DNCB), used for comparison 
purposes, caused severe erythema, edema and ef-
fusion characteristic of contact hypersensitivity. 
CONCLUSIONS
In the present experiment it was demonstrated 
that AX/09 modifi es and normalizes the process of 
burn wound healing. There were no toxicodermal 
reactions, neither after the fi rst contact with the 
skin nor after 10 days of treatment with AX/09. 
The vehiculum that was used did not show any ir-
ritating effects either. Moreover, the skin test with 
vehiculum and AX/09 did not reveal any propen-
sity to cause contact allergy in any of the animals 
tested.
In chemical burns AX/09 caused termination 
of the wound healing process, i.e. the complete 
closure of the wound by the newly formed epider-
mis, after 17 days. In the control group the same 
effect was observed after 23 days. In thermal bur-
ns AX/09 enhanced the granulation and new skin 
formation on the surface of the wound as com-
pared with the control group. AX/09 considera-
bly reduced infl ammation and effusion within the 
wound, which was manifested by a faster decline 
in skinfold thickness measured micrometrically. 
The effi cacy of AX/09 and its infl uence on the 
burn wound healing process, particularly in che-
mical models, seems to be of special value for the 
clinical, especially dermatological, practice. 
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